Vedolizumab was similarly effective as infliximab in the control of arthralgias in patients with inflammatory bowel disease (IBD) in the real world, suggests a head-to-head study presented at the Crohn's & Colitis Congress (CCC) 2020.
Children with inflammatory bowel disease (IBD) do not appear to have an elevated risk of lymphoma following treatment with anti-tumour necrosis factor (TNF) agents, according to a study presented at the recent Crohn’s and Colitis Congress 2020.
Children with ulcerative colitis (UC) who undergo a proctocolectomy may have an increased risk of readmission to hospital 30 days after their initial hospital admission, according to a retrospective cohort study presented at the recent Crohn’s and Colitis Congress 2020.
Obesity does not appear to be strongly correlated with an increased risk for febrile neutropaenia during levofloxacin prophylaxis in patients with haematological malignancies receiving intermediate-risk myelosuppressive chemotherapy, suggests a study.
Initiation or switch to the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) led to low HIV-1 RNA viral load in people living with HIV (PLHIV), according to the BICSTaR study presented at HIV Glasgow 2020.
Use of corticosteroids appears to be an effective treatment for paediatric drug reaction with eosinophilia and systemic symptoms (DRESS), suggest the results of a recent study. In severe cases, corticosteroids used in conjunction with intravenous immunoglobulin result in fast clinical improvement.